
Ekso Bionics Holdings EKSO
Quarterly report 2026-Q1
added 04-28-2026
Ekso Bionics Holdings Long Term Debt Current 2011-2026 | EKSO
Annual Long Term Debt Current Ekso Bionics Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 441 K | 427 K | 363 K | 341 K | 229 K | 548 K | 421 K | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 548 K | 229 K | 396 K |
Long Term Debt Current of other stocks in the Medical instruments industry
| Issuer | Long Term Debt Current | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
The Cooper Companies
COO
|
37.8 M | $ 60.58 | 0.33 % | $ 12.1 B | ||
|
iRhythm Technologies
IRTC
|
16.7 M | $ 115.46 | 1.14 % | $ 3.7 B | ||
|
ICU Medical
ICUI
|
13.8 M | $ 120.37 | -2.13 % | $ 2.97 B | ||
|
Repro Med Systems
KRMD
|
413 K | $ 3.87 | -2.76 % | $ 179 M | ||
|
Intuitive Surgical
ISRG
|
39 M | $ 421.73 | -1.48 % | $ 151 B | ||
|
LeMaitre Vascular
LMAT
|
2.94 M | $ 97.52 | -1.99 % | $ 2.21 B | ||
|
Alcon
ALC
|
80 M | $ 63.93 | -0.14 % | $ 40.4 B | ||
|
Masimo Corporation
MASI
|
21.4 M | $ 178.4 | 0.03 % | $ 9.51 B | ||
|
Envista Holdings Corporation
NVST
|
39 M | $ 23.69 | -0.67 % | $ 3.98 B | ||
|
electroCore
ECOR
|
375 K | $ 6.29 | -2.18 % | $ 53.4 K | ||
|
Haemonetics Corporation
HAE
|
8.11 M | $ 56.6 | -0.86 % | $ 2.85 B | ||
|
STAAR Surgical Company
STAA
|
5.87 M | $ 32.27 | 0.81 % | $ 1.6 B | ||
|
STERIS plc
STE
|
34.2 M | $ 214.08 | -0.88 % | $ 21.1 B | ||
|
Teleflex Incorporated
TFX
|
100 M | $ 128.92 | -1.04 % | $ 5.75 B | ||
|
Isoray
ISR
|
623 K | - | 0.03 % | $ 108 M | ||
|
Glaukos Corporation
GKOS
|
1.31 M | $ 141.43 | -0.52 % | $ 6.85 B | ||
|
InfuSystem Holdings
INFU
|
349 K | $ 8.57 | -0.46 % | $ 177 M | ||
|
Microbot Medical
MBOT
|
296 K | $ 1.93 | 4.32 % | $ 88.4 M | ||
|
Milestone Scientific
MLSS
|
130 K | $ 0.33 | -1.64 % | $ 27.1 M | ||
|
Merit Medical Systems
MMSI
|
10.9 M | $ 62.4 | -0.26 % | $ 3.69 B | ||
|
Utah Medical Products
UTMD
|
60 K | $ 63.24 | -0.72 % | $ 205 M | ||
|
West Pharmaceutical Services
WST
|
22.7 M | $ 301.39 | 0.4 % | $ 21.8 B | ||
|
Pulse Biosciences
PLSE
|
1.57 M | $ 24.12 | -11.01 % | $ 1.63 B | ||
|
DENTSPLY SIRONA
XRAY
|
47 M | $ 10.04 | -3.6 % | $ 2 B | ||
|
Retractable Technologies
RVP
|
286 K | $ 0.69 | - | $ 20.7 M | ||
|
Predictive Oncology
POAI
|
654 K | - | - | $ 31.1 M | ||
|
BioLife Solutions
BLFS
|
2.24 M | $ 20.55 | -2.42 % | $ 981 M | ||
|
Stereotaxis
STXS
|
642 K | $ 1.87 | -3.86 % | $ 170 M | ||
|
Baxter International
BAX
|
81 M | $ 17.32 | -2.64 % | $ 8.89 B | ||
|
ResMed
RMD
|
21.9 M | $ 202.53 | -0.01 % | $ 29.6 B | ||
|
AtriCure
ATRC
|
1.73 M | $ 28.37 | 0.79 % | $ 1.35 B | ||
|
Harvard Bioscience
HBIO
|
1.52 M | $ 5.36 | -2.9 % | $ 238 M | ||
|
NeuroMetrix
NURO
|
107 K | - | 5.05 % | $ 9.02 M | ||
|
AngioDynamics
ANGO
|
1.84 M | $ 10.88 | -1.36 % | $ 444 M | ||
|
Becton, Dickinson and Company
BDX
|
135 M | $ 142.79 | -1.2 % | $ 41.1 B | ||
|
Nephros
NEPH
|
386 K | $ 3.16 | -5.39 % | $ 33.5 M | ||
|
OraSure Technologies
OSUR
|
2.16 M | $ 3.08 | 4.24 % | $ 226 M | ||
|
Repligen Corporation
RGEN
|
21.6 M | $ 105.36 | 1.91 % | $ 5.92 M |